4.6 Meeting Abstract

A multi-centre phase IIB randomized controlled study of BLP25 liposome vaccine (L-BLP25 or Stimuvax) for active specific immunotherapy of non-small cell lung cancer (NSCLC): updated survival analysis

Journal

JOURNAL OF THORACIC ONCOLOGY
Volume 2, Issue 8, Pages S332-S333

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/01.JTO.0000283139.22682.5e

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available